Publicaciones en las que colabora con Esteban Orenes Piñero (23)

2023

  1. High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

    IJC Heart and Vasculature, Vol. 46

  2. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    American Heart Journal, Vol. 258, pp. 1-16

  3. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    FASEB Journal, Vol. 37, Núm. 6

2022

  1. Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review

    Reviews in Cardiovascular Medicine, Vol. 23, Núm. 12

  2. Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors

    Diabetes Research and Clinical Practice, Vol. 184

  3. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  4. Novel insights in the relationship of gut microbiota and coronary artery diseases

    Critical Reviews in Food Science and Nutrition, Vol. 62, Núm. 14, pp. 3738-3750

2021

  1. Antithrombotic therapy in patients with peripheral artery disease: A focused review on oral anticoagulation

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

  2. Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: A review of potential implications

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-16

  3. Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

    Critical Reviews in Clinical Laboratory Sciences, Vol. 58, Núm. 3, pp. 167-179

2020

  1. One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1052-1061

2019

  1. Chronic Kidney Disease and Third-Generation P2Y 12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

    Journal of Clinical Pharmacology, Vol. 59, Núm. 2, pp. 295-302

  2. Switching of Oral P2Y 12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis

    Clinical Drug Investigation, Vol. 39, Núm. 3, pp. 275-283

  3. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome

    European Journal of Internal Medicine, Vol. 61, pp. 48-53

  4. Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease

    Minerva Medica, Vol. 110, Núm. 5, pp. 410-418

2018

  1. Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

    PLoS ONE, Vol. 13, Núm. 11

  2. Disparities in the estimation of glomerular filtration rate according to cockcroft-gault, modification of diet in renal disease-4, and chronic kidney disease epidemiology collaboration equations and relation with outcomes in patients with acute coronary syndrome

    Journal of the American Heart Association, Vol. 7, Núm. 9

  3. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

    American Journal of Cardiology, Vol. 122, Núm. 5, pp. 785-792

  4. Impact of support networks for breastfeeding: A multicentre study

    Women and Birth, Vol. 31, Núm. 4, pp. e239-e244

  5. Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 23, Núm. 1, pp. 57-65